Putative environmental-endocrine disruptors and obesity: A review

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 15, Issue 5, 2008, Pages 403-408

  Elobeid, Mai A ^a   Allison, David B ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama ^*  (United States)

Author keywords

Bisphenol A; Butyltins; Endocrine disruptors; Obesity; Phthalates

Indexed keywords

4 NONYLPHENOL; 4,4' ISOPROPYLIDENEDIPHENOL; AROMATIC HYDROCARBON; BUTYLTIN; ENDOCRINE DISRUPTOR; ENVIRONMENTAL CHEMICAL; HALOGENATED HYDROCARBON; INDUSTRIAL CHEMICAL; PHTHALIC ACID; POLYCHLORINATED DIBENZODIOXIN; SUCROSE POLYESTER; TRIBUTYLTIN;

ADIPOSE TISSUE; ENDOCRINE SYSTEM; ENVIRONMENTAL FACTOR; EPIDEMIC; EPIDEMIOLOGICAL DATA; EXPERIMENTAL STUDY; HORMONAL REGULATION; HUMAN; LABORATORY TEST; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; WEIGHT GAIN;

ANIMALS; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; HORMONES; HUMANS; OBESITY;

EID: 53549094651     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e32830ce95c     Document Type: Review

References (74)

1. Newbold RR, Padilla-Banks E, Snyder RJ, et al. Developmental exposure to endocrine disruptors and the obesity epidemic. Reprod Toxicol 2007; 23: 290-296. Evaluation of the association between endocrine disruptors and the development of obesity.
2. Damstra T. Potential effects of certain persistent organic pollutants and endocrine disrupting chemicals on the health of children. Clin Toxicol 2002; 40:457-465.
3. Shinomiya N, Shinomiya M. Dichlorodiphenyltrichloroethane suppresses neurite outgrowth and induces apoptosis in PC12 pheochromocytoma cells. Toxicol Lett 2003; 137:175-183.
4. Ogden CL, Regal KM, Carroll MD, et al. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288:1728-1732.
5. Regal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288:1723-1727.
6. Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004; 291:2847-2850.
7. NIH. Strategic plan for NIH obesity research, http://obesityresearch.nih. gov/About/Obesity_EntireDocument.pdf. 2004.
8. USDA. Future directions for CSREES obesity prevention workshop. Obesity Prevention Planning Workshop: summary of responses. http://www.csrees. usda.gov/nea/food/pdfs/obesity_summary.pdf. 2004.
9. WHO. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization; 1998.
10. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295:1549-1552.
11. Janssen I, Katzmarzyk FT, Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med 2002; 162:2074-2079.
12. Folsom AR, Kaye SA, Sellers TA, et al. Body fat distribution and 5-year risk of death in old women. JAMA 1993; 269:483-487.
13. Seidell JC, Bjomtorp P, Sjostrom L, et al. Regional distribution of muscle and fat mass in men: new insight into the risk of abdominal obesity using computed tomography. Int J Obes 1989; 13:289-293.
14. Haffner SM, Vaktez RA, Hazed HP, et al. Prospective analysis of the insulinresistance syndrome (syndrome X). Diabetes 1992; 41:715-722.
15. Despres JP. Abdominal obesity as an important component of insulin-resistance syndrome. Nutrition 1993; 9:452-459.
16. Ross R, Freeman J, Hudson R, et al. Abdominal obesity, muscle composition, and insulin resistance in premenopausal worried. J Clin Endocrinol Metab 2002; 87:5044-5051.
17. Ivandic A, Prpic-Krizevac I, Bozic D, et al. Insulin resistance and androgens in healthy women with different body fat distributions. Wien Klin Wochenschr 2002; 114:321-326.
18. Stoll BA. Upper abdominal obesity, insulin resistance and breast cancer risk. Int J Obes Relat Metab Disord 2002; 26:747-753.
19. Le ML, Wilkens LR, Mi MP. Obesity in youth and middle age and risk of colorectal cancer in men. Cancer Causes Control 1992; 3:349-354.
20. Moyad MA. Obesity, interrelated mechanisms, and exposures and kidney cancer. Semin Urol Oncol 2001; 19:270-279.
21. Allison DB, Downey M, Atkinson RL, et al. Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society (TOS). Obesity 2008; 16:1161-1177.
22. Baillie-Hamilton PF. Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med 2002; 8:185-192.
23. United States Tariff Commission. Synthetic organic chemicals. Washington: U.S. Government Printing Office (various documents), 1918-1994.
24. Newbold RR, Padilla-Banks E, Jefferson WN, et al. Effects of endocrine disruptors on obesity. Int J Androl 2008; 31:201-208.
25. Iguchi T, Watanabe H, Katsu Y. Toxicogenomics and ecotoxicogenomics for studying endocrine disruption and basic biology. Gen Comp Endocrinol 2007; 153:25-29. A review of the potential molecular mechanisms of action of endocrine disruptor in animals.
26. Mullerova D, Kopecky J. White adipose tissue: storage and effector site for environmental pollutants. Physiol Res 2006; 56:375-381.
27. Grün F, Blumberg B. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 2006; 147:S50-S55.
28. Sakurai K, Kawazuma M, Adachi T, et al. Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br J Pharmacol 2004; 141:209-214.
29. Masuno H, Kidani T, Sekiya K, et al. Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J Lipid Res 2002; 43:676-684.
30. Masuno H, Iwanami J, Kidani T, et al. Bisphenol A accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci 2005; 84:319-327.
31. Howdeshell KL, vom Saal FS. Developmental exposure to bisphenol A: interaction with endogenous estradiol during pregnancy in mice. Am Zool 2000; 40:429-437.
32. Howdeshell KL, Hotchkiss AK, Thayer KA, et al. Exposure to bisphenol A advances puberty. Nature 1999; 401:763-764.
33. Takai Y, Tsutsumi O, Ikezuki Y, et al. Estrogen receptor-mediated effects of a xenoestrogen, bisphenol A, on preimplantation mouse embryos. Biochem Biophys Res Commun 2000; 270:918-921.
34. Honma S, Suzuki A, Buchanan DL, et al. Low dose effect of in utero exposure to bisphenol A and diethylstilbestrol on female mouse reproduction. Reprod Toxicol 2002; 16:117-122.
35. Nikaido Y, Yoshizawa K, Danbara N, et al. Effects of maternal xenoestrogen exposure on development of the reproductive tract and mammary gland in female CD-1 mouse offspring. Reprod Toxicol 2004; 18:803-811.
36. Miyawaki J, Sakayama K, Kato H, et al. Perinatal and Postnatal Exposure to bisphenol A increases adipose tissue mass and serum cholesterol level in mice. J Atheroscler Thromb 2007; 5:245-252.
37. Rubin BS, Murray MK, Damassa DA, et al. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect 2001; 109:675-680.
38. Nunez AA, Kannan K, Giesy JP, et al. Effects of bisphenol A on energy balance and accumulation in brown adipose tissue in rats. Chemosphere 2001; 42:917-922.
39. Seidlová-Wuttke D, Jarry H, Christoffel J, et al. Effects of bisphenol-A (BPA), dibutylphtalate (DBP), benzophenone-2 (BP2), procymidone (Proc), and linurone (Lin) on fat tissue, a variety of hormones and metabolic parameters: A 3 months comparison with effects of estradiol (E2) in ovariectomized (ovx) rats. Toxicology 2005; 215:13-24.
40. Zoeller RT, Bansal R, Parris C, et al. Bisphenol A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. Endocrinology 2005; 146:607-612.
41. Tyl R, Myers C, Marr M, et al. Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague Dawley rats. Toxicol Sci 2002; 68:121-146.
42. Kim HS, Han SY, Yoo SD, et al. Potential estrogenic effects of bisphenol-A estimated by in vitro and in vivo combination assays. J Toxicol Sci 2001; 26:111-118.
43. Vandenberg LN, Maffini MV, Wadia PR, et al. Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology 2007; 148:116-127.
44. Beck JC, Hosick HL. Growth of mouse mammary epithelium in response to serum-free media conditioned by mammary adipose tissue. Cell Biol Int Rep 1998; 12:85-97.
45. Rudland PS, Twiston-Davies AC, Tsao SW. Rat mammary preadipocytes in culture produce a trophic agent for mammary epithelia-prostaglandin E2. J Cell Physiol 1984; 120:364-376.
46. Tabb MM, Blumberg B. New modes of action for endocrine-disrupting chemicals. Mol Endocrinol 2006; 20:475-482.
47. Forman BM, Tontonoz P, Chen J. 15-Deoxy-γ12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 1995; 83:803-812.
48. Schoonjans K, Staels B, Auwerx J. The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1996; 1302:93-109.
49. Kersten S. Peroxisome proliferator activated receptors and obesity. Eur J Pharmacol 2002; 440:223-234.
50. Xue JC, Schwaz EJ, Chawla A, et al. Distinct stages in adipogenesis revealed by retinoid inhibition of differentiation after induction of PPARγ. Mol Cell Biol 1996; 16:1567-1575.
51. Kawada T, Kamei Y, Sugimoto E. The possibility of active form of vitamins A and D as suppressors on adipocyte development via ligand-dependent transcriptional regulators. Int J Obes Relat Metab Disord 1996; 20:S52-S57.
52. Kawada T, Kamei Y, Fujita A, et al. Carotenoids and retinoids as suppressors on adipocyte differentiation via nuclear receptors. Biofactors 2000; 13:103-109.
53. Grün F, Watanabe H, Zamanian Z, et al. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol 2006; 20:2141-2155.
54. Inadera H, Shimomura A. Environmental chemical tributyltin augments adipocyte differentiation. Toxicol Lett 2005; 159:226-234.
55. Masuno H, Okamoto S, Iwanami J, et al. Effect of 4-nonylphenol on cell proliferation and adipocyte formation in cultures of fully differentiated 3T3-L1 cells. Toxicol Sci 2003; 75:314-320.
56. Hoppe AA, Carey GB. Polybrominated Diphenyl ethers as endocrine disruptors of adipocyte metabolism. Obesity 2007; 15:2942-2950. The role of PBDE in obesity in animals.
57. Irigaray P, Newby JA, Clapp R, et al. Lifestyle-related factors and environmental agents causing cancer: an overview. Biomed Pharmacother 2007; 61:640-658.
58. Geyer HJ, Schramm KW, Scheunert I, et al. Considerations on genetic and environmental factors that contribute to resistance or sensitivity of mammals including humans to toxicity of 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Part 1: genetic factors affecting the toxicity of TCDD. Ecotoxicol Environ Saf 1997; 36:213-230.
59. Mead MN. Origins of obesity: chemical exposures. Environ Health Perspect 2004; 112:A344.
60. Wittassek M, Wiesmüller GA, Koch HM, et al. Internal phthalate exposure over the last two decades: a retrospective human biomonitoring study. Int J Hyg Environ Health 2007; 210:319-333. An epidemiological study on monitoring of phthalates exposure.
61. Calafat AM, Kuklenyik Z, Reidy J A, et al. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 2005; 113:391-395.
62. Pelletier C, Despres JP, Tremblay A. Plasma organochlorine concentrations in endurance athletes and obese individuals. Med Sci Sports Exerc 2002; 34:1971-1975.
63. Chevrier J, Dewailly E, Ayotte P, et al. Body weight loss increases plasma and adipose tissue concentrations of potentially toxic pollutants in obese individuals. Int J Obes Relat Metab Disord 2000; 24:1272-1278.
64. Is it in all of us? Chemical contamination of our bodies. A report from the body burden work group and commonweal biomonitoring resource center. 2007. http://www.isitinus.org/project.php The report exposes the reality of toxic chemicals in our lives.
65. Goncharov A, Haase RF, Santiago-Rivera A, et al. High serum PCBs are associated with elevation of serum lipids and cardiovascular disease in a Native American population. Environ Res 2008; 106:226-239.
66. Hue O, Marcotte J, Berrigan F, et al. Plasma concentration of organochlorine compounds is associated with age and not obesity. Chemosphere 2007; 67:1463-1467.
67. Takeuchi T, Tsutsumi O, Ikezuki Y, et al. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J 2004; 51:165-169.
68. Pelletier C, Doucet E, Imbeault P, et al. Associations between weight lossinduced changes in plasma organochlorine concentrations, serum T(3) concentration, and resting metabolic rate. Toxicol Sci 2002; 67:46-51.
69. Lee DH, Lee IK, Song KE, et al. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey. Diabetes Care 2006; 29:1638-1644.
70. Lee DH, Lee IK, Jin SH, et al. Association between serum concentrations of persistent organic pollutants and insulin resistant among nondiabetic: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2007; 30:622-628.
71. Stahlhut RW, Wijngaarden EV, Dye TD, et al. Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ Health Perspect 2007; 115:876-882. Evaluation of phthalates metabolites and abdominal obesity among adult US males.
72. Fein GG, Jacobson JL, Jacobson SW, et al. Prenatal exposure to polychlonnated biphenyls: effects on birth size and gestational age. J Pediatr 1984; 105:315-320.
73. Givens ML, Small CM, Terrell ML, et al. Maternal exposure to polybrominated and polychlorinated biphenyls: infant birth weight and gestational age. Chemosphere 2007; 69:1295-1304.
74. Redgrave TG, Wallace P, Jandacek RJ, et al. Treatment with a dietary fat substitute decreased Aroclor 1254 contamination in an obese diabetic male. J Nutr Biochem 2005; 16:383-384.